Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Better Plant offers plant-based products for optimum health and wellness. It is a vertically integrated company with a team whose complementary experience enables acquisition, development, manufacturing, and direct-to-consumer distribution of its products. Its all-natural products vary from juice cleanses to home products to personal care products, all without chemicals or harmful ingredients. It has an extensive catalogue of over 400 proprietary plant-based product formulas. Better Plant currently has over 70 plant-based products for sale through eCommerce and/or in retail stores under the brands Jusu, Urban Juve, and Wright & Well. Better Plant also offers operational and support services to companies in which it has an equity interest. Better Plant also owns approximately 27.7% of NeonMind Biosciences Inc. (CSE:NEON). 

BetterLife Pharma Inc. (“BetterLife”) is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Through its wholly owned subsidiary, Altum Pharmaceuticals Inc., BetterLife is refining and developing drug candidates from a broad set of complementary Interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumours to treat specific types of cancer.

BevCanna Enterprises Inc. seeks to develop and manufacture cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 100-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 72M bottles. BevCanna’s vision is to be the global leader infused innovations.

Make the fairly enjoyable ridiculously fun! For over a decade, Bhang has delivered exceptional sensory experiences to consumers through its extensive portfolio of over 50 master-chef created cannabis, CBD, and terpene products including highly-awarded gourmet chocolates, pre-rolls, CBD isolate, and Hempsticks™. Bhang’s gourmet, cannabis-infused chocolates are among the top-selling edibles in 7 U.S. states and Canada. Bhang’s CBD products are globally-distributed and known for being safe, efficacious and delicious. 

Investor Note: In addition to the 107,358,457 Subordinate Voting Shares that are listed and trading, there are 47,292,501 Subordinate Voting Shares reserved for issuance pursuant to the conversion rights attached to other classes of equity shares that are issued and outstanding but not listed. The total number of issued shares assuming all equity shares are converted into the listed class would be 154,650,958.

 

Biocure Technology Inc. is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting pre-clinical trials of its biosimilar candidates of Interferon Beta 1b, PEG-Filgrastim and Ranibizumab as well as CAR-T Cell Therapy.

BioHarvest Sciences produces and sells a food-based Nutraceutical product called ViniaTM  which contains the whole range of piceid resveratrol in natural state . The product is made by growing plant cells from red grapes in bioreactors utilizing the Issuer’s platform technology which allows the growing of specific cells instead of the whole plant. The Issuer is also completing research to adapt its platform technology to growing of cannabis cells under a cannabis research license in Israel.

BioMark is a Canadian based company that is developing its advanced stage cancer diagnostic business. BioMark’s cancer diagnostics technology platform leverages "Omics" and machine learning which allows for early cancer detection. BioMark is currently focused on bringing its cancer diagnostic kits and detection solution to commercialization standards and hopes to commence distribution once clinical trials are complete and regulatory acceptance is obtained. For more information please visit the company’s website at www.biomarkdiagnostics.com

Biome Grow Inc. (CSE:BIO) is a Canadian cannabis company with operations mainly concentrated in Atlantic Canada.   The company wholly owns five subsidiaries, including: The Back Home Medical Cannabis Corporation, a company incorporated under the laws of the Province of Newfoundland and Labrador and in the late stages of applying for a license under the Cannabis Act; Great Lakes Cannabis, an Ontario company also in the late stages of applying for a license; Highland Grow Inc., a licensed producer in Nova Scotia; Red Sands Craft Cannabis Co., a Prince Edward Island company set up to provide extraction services; and Weed Virtual Retail Inc., an Ontario company in the business of operating a new virtual reality technology and education platform.  In addition to these domestic cultivation and distribution assets, Biome also has five retail licenses in Newfoundland with stores opening this year as well as a significant MOU to be supplied a large quantity of CBD from a third-party supplier.  The company hopes to leverage the CBD business both at home and abroad by producing and exporting a range of CBD infused products starting late 2019.

BioVaxys Technology Corp. is a clinical-stage immunotherapeutics company developing vaccine platforms for SARS-CoV-2 and various cancers.

Blueberries Medical Corp. (Blueberries) is seeking to become a large scale producer of naturally grown premium quality cannabis with its primary operations well situated in the Bogotá savanna in central Colombia. Lead by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries has received all licenses required for the cultivation, production, domestic distribution, and international export of CBD (cannabidiol) and THC (tetrahydrocannabinol)-based medical cannabis. Blueberries’ combination of leading scientific expertise, agricultural advantages, and distribution arrangements has positioned the company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-04-22-Earth-Day_Website.jpg

The CSE Celebrates: Earth Day!

Thursday, April 22, 2021 -
4:00pm to 5:00pm

Advertisement

Publicité